Daniel R. Eliav is a California licensed attorney with expertise in helping clients navigate through the myriad of healthcare laws and regulations to achieve their strategic goals. He has broad experience in the areas of telemedicine, corporate practice of medicine restrictions, licensing, and reimbursement. In addition, Daniel has regularly provided counsel on state and federal fraud and abuse issues, including the Stark Law, the anti-kickback statute, and civil monetary penalties laws. He has helped multiple clients overcome obstacles with regulatory agencies, allowing clients more flexibility to develop and operate their business.
In a previous role, Daniel served as an attorney for the state of California, helping to establish that state’s Health Benefit Exchange under the Affordable Care Act. In private practice, Daniel worked with multiple Accountable Care Organizations to help register and ensure compliance with the Medicare Shared Savings Program (MSSP), Next Generation ACO Model, and Episode Based Payment Initiatives such as the Bundled Payments for Care Improvements (BPCI) Initiative and the Comprehensive Care for Joint Replacement (CJR) Model. In addition, Daniel has assisted with establishing commercial accountable care organizations and clinically integrated networks (CINs) that work directly with health plans and self-insured employers. Daniel has also worked extensively with behavioral health providers such as Residential Treatment Facilities (RTFs), outpatient mental health clinics, and Applied Behavioral Analysis (ABA) providers.
Daniel has worked closely with employer sponsored insurance plans to implement cutting edge solutions, including wellness programs, on-site employee clinics, digital health solutions, and robust pharmacy-benefit plans. Daniel has also helped third-party administrators enter into and develop new markets.
In addition, Daniel has provided counsel on compliance with the Health Information Portability and Accountability Act (HIPAA), reimbursement issues under Medicare and Medicaid, the Emergency Medical Transfer and Labor Act (EMTALA), the Clinical Lab Improvement Amendments (CLIA), physician advertising, and consent issues.